Deal Detail

NutraQ to Orkla Health

EV / LTM EBITDA

16.5x

EV / LTM Sales

3.6x

Enterprise Value

$367M

Primary Source

Company Release

Comparable Transactions

Consumer Health transactions announced in the five years to February 2021. 5 with a disclosed multiple.

Date	Target	Acquiror	Enterprise Value	EV/Sales	EV/EBITDA	Type
Dec 2020	Biogix, Inc.	Alliance Pharma plc	$110M	-	15.7x	Strategic
May 2019	Ranir Global Holdings LLC	Perrigo Company plc	$750M	2.6x	-	Strategic
Dec 2018	Nutrisystem, Inc.	Tivity Health, Inc.	$1.3B	-	12.6x	Strategic
Apr 2018	Merck KGaA (consumer health business)	The Procter & Gamble Company	$4.2B	-	19.5x	Strategic
May 2017	Nutraceutical International Corp.	HGGC LLC	-	-	9.2x	Strategic
	Mean			-	14.3x
	Median			-	14.1x

Source-specific multiples and notes for this transaction.

Primary?	Source Type	Fairness Opinion / Source	Advisor	Source Year	Enterprise Value	EV/Sales	EV/EBITDA	EV/Fwd EBITDA	Note	Citation
Primary	press release	Press Release	-	2021	$367M	3.6x	16.5x	-	EV based on USD:NOK FX of 8.45 as announcement date.	Open